STOCK TITAN

Clorox (CLX) COO Chris Hyder receives 42,118-share stock grant, now holds 77,087

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Hyder Chris T reported acquisition or exercise transactions in this Form 4 filing.

Clorox executive Chris T. Hyder received a stock grant that increases his direct holdings. He was awarded 42,118 shares of Clorox common stock on June 17, 2026, as a grant or award valued at $94.97 per share. After this grant, he directly holds 77,087 shares. A related footnote states that these Restricted Stock Units will vest in full on June 17, 2029, three years after the grant date.

Positive

  • None.

Negative

  • None.
Insider Hyder Chris T
Role EVP-Chief Operating Officer
Type Security Shares Price Value
Grant/Award Common Stock 42,118 $94.97 $4.00M
Holdings After Transaction: Common Stock — 77,087 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Stock grant size 42,118 shares Common stock award on June 17, 2026
Grant valuation price $94.97 per share Recorded price for the 42,118-share award
Total holdings after grant 77,087 shares Direct ownership following the transaction
RSU vesting date June 17, 2029 Restricted Stock Units vest in full on this date
Restricted Stock Units financial
"The Restricted Stock Units will vest in full on the third anniversary of the grant date"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
grant date financial
"third anniversary of the grant date, June 17, 2029"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
transaction code financial
"transaction code: "A" ... "Grant, award, or other acquisition""
direct ownership financial
"total_shares_following_transaction ... ownership_type: "direct""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hyder Chris T

(Last)(First)(Middle)
1221 BROADWAY

(Street)
OAKLAND CALIFORNIA 94612-1888

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP-Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/17/2026A(1)42,118A$94.9777,087D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The Restricted Stock Units will vest in full on the third anniversary of the grant date, June 17, 2029.
By Jinho Joo, Attorney-in-Fact06/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Clorox (CLX) EVP Chris Hyder report in this Form 4?

Chris T. Hyder reported receiving a grant of 42,118 shares of Clorox common stock. The award was recorded at $94.97 per share, increasing his direct holdings to 77,087 shares following the grant.

Is the Chris Hyder Form 4 for CLX a stock purchase or a grant?

The Form 4 shows a stock grant or award, not an open-market purchase. The transaction code is “A,” described as a grant, award, or other acquisition, and it added 42,118 shares to his direct holdings.

How many Clorox (CLX) shares does Chris Hyder hold after this transaction?

After the grant, Chris T. Hyder directly holds 77,087 shares of Clorox common stock. This total reflects his position immediately following the 42,118-share award reported in the Form 4.

What is the vesting schedule for Chris Hyder’s Clorox Restricted Stock Units?

The footnote explains that the Restricted Stock Units will vest in full on June 17, 2029. This date is the third anniversary of the grant date, meaning the entire award becomes fully vested at that time.

Did Chris Hyder sell any Clorox (CLX) shares in this Form 4 filing?

No share sales are reported in this filing. The transaction summary shows one acquisition and zero disposals, and the single transaction is coded as a grant or award of 42,118 shares.